3'-Fluoro-3'-deoxythymidine (Alovudine)

3'-Fluoro-3'-deoxythymidine (Alovudine) (CAS No.: 25526-93-6) is a synthetic fluorinated thymidine nucleoside analog broadly categorized as a nucleic acid metabolism probe and antiviral lead scaffold for biomedical research, with primary utility in studies of DNA replication dynamics, mitochondrial biology, and viral polymerase function. In mechanistic terms, it is reported to inhibit reverse transcriptase and mitochondrial DNA polymerase gamma, thereby modulating nucleoside incorporation and suppressing mitochondrial DNA synthesis, and it is consequently used to investigate polymerase dependent pathways linked to genome maintenance, replication stress, and nucleotide analog responses in transformed cell systems. As a thymidine based DNA synthesis marker, it has been applied in oncology research contexts, including pancreatic cancer experimental paradigms, where nucleoside tracer behavior is described as less confounded by inflammatory background than FDG based metabolic readouts, supporting its value in translational biomarker method development rather than clinical decision use. Reported bioactivity in the literature for related antiviral and polymerase inhibition assays is generally described within nanomolar to micromolar ranges depending on assay format, enzyme source, and cellular background, while potency in any given platform should be empirically confirmed under laboratory specific conditions. Typical applications include in vitro cell proliferation and nucleoside transport studies, viral replication and resistance profiling, mitochondrial toxicity mechanistic assessments, and in vivo proof of concept pharmacology or imaging biomarker workflows in preclinical animal models, where the concentrations or doses used in experiments typically depend on specific experimental designs and research objectives.